Topiramate Compared to Acetazolamide in Treatment of Idiopathic Intracranial Hypertension

Abstract

The efficacy of topiramate in the treatment of idiopathic intracranial hypertension (IIH) was compared to acetazolamide in an open-label study of 40 patients (age range 16-50, median 32 years; male/female ratio 5/35) at Ege University Medical School, Izmir, Turkey.

Keywords

• idiopathic intracranial hypertension
• acetazolamide
• topiramate